Gene expression signature of tolerance and lymphocyte subsets in stable renal transplants: Results of a cross-sectional study

Transplant Immunology

Volumn 31, Issue 1, 2014, Pages 11-16

  Moreso, Francesc ^a   Torres, Irina B ^a   Martínez Gallo, Monica ^a   Benlloch, Susana ^b   Cantarell, Carme ^a   Perelló, Manel ^a   Jimeno, José ^b   Pujol Borrell, Ricardo ^a   Seron, Daniel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Immunology Department Hospital Universitari Vall d'Hebron Universitat Autònoma de Barcelona ^*  (Spain)

Author keywords

B cells; Chronic rejection; Immunosuppression; Lymphocyte subpopulations; Operational tolerance; Renal transplantation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOSUPPRESSIVE AGENT; TRANSCRIPTOME;

ADULT; ARTICLE; B LYMPHOCYTE; CHRONIC GRAFT REJECTION; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC TOLERANCE SIGNATURE; HUMAN; IGKV1D 13 GENE; IGKV4 1 GENES; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; DNA MICROARRAY; DRUG EFFECTS; GENETICS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AZATHIOPRINE; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CALCINEURIN INHIBITORS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84903769433     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2014.04.008     Document Type: Article

References (24)

1. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341:1725-1730.
2. Meier-Kriesche H.U., Schold J.D., Kaplan B. Long term renal allograft survival: have we made significant progress or is time to rethink our analytic and therapeutic strategies?. Am J Transplant 2004, 4:1289-1295.
3. Seron D., Moreso F., Arias M., Campistol J.M., Curto J., Hernandez D., et al. Estimation of renal allograft half-life: fact or fiction?. Nephrol Dial Transplant 2011, 26:3013-3018.
4. Registre de Malalts Renals de Catalunya Statistical Report 2009 August 2011, [Barcelona]. Servei Catala de la Salut, Organització Catalana de Trasplantaments (OCATT) (Eds.).
5. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., Chapman J.R. The natural history of chronic allograft nephropathy. N Engl J Med 2003, 349(24):2326-2333.
6. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Chapman J.R., Allen R.D. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004, 78:557-565.
7. Miller L.W. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002, 2:807-818.
8. London N.J., Farmery S.M., Will E.J., Davison A.M., Lodge J.P.A. Risk of neoplasia in renal transplant patients. Lancet 1995, 346:403-406.
9. United States Renal Data System USRDS 2008 Annual Data Report Available at:, [Accessed November 8, 2009]. http://www.usrds.org.
10. Hazzan M., Labalette M., Copin M.C., Glowacki F., ProvÔt F., Pruv F.R., et al. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective randomized trial. J Am Soc Nephrol 2005, 16:2509-2516.
11. Sellarés J., de Freitas D.G., Mengel M., Reeve J., Einecke G., Sis B., et al. Understanding the causes of kidney transplant failure: the dominant role of antibody mediated rejection and non-adherence. Am J Transplant 2012, 12:388-399.
12. Brouard S., Le Bars A., Dufay A., Gosselin M., Foucher Y., Guillet M., et al. Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant recipients. Transpl Int 2011, 24:536-547.
13. Martínez-Llordella M., Lozano J.J., Puig-Pey I., Orlando G., Tisone G., Lerut J., et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008, 118:2845-2857.
14. Brouard S., Mansfield E., Braud C., Li L., Giral M., Hsieh S.C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci 2007, 10(39):15448-15453.
15. Sagoo P., Perucha E., Sawitzki B., Tomiuk S., Stephens D.A., Miqueu P., et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 1848-1861, 120(6):2010.
16. Newell K.A., Asare A., Kirk A.D., Gisler T.D., Bourcier K., Suthanthiran M., et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 1836-1847, 120(6):2010.
17. Roussey-Kesler G., Giral M., Moreau A., Subra J.F., Legendre C., Noël C., et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006, 6:736-746.
18. Brouard S., Pallier A., Renaudin K., Foucher Y., Danger R., Devys A., et al. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant 2012, 12:3296-3307.
19. Benitez C., Lozano J.J., Martinez-Llordella M., Puig-Pey I., Lopez M., Rodriguez A., et al. Use of transcriptional biomarkers to identify liver transplant recipients who can successfully discontinue immunosuppressive therapy (abstr 213). Am J Transplant 2009, 9:252.
20. Benítez C., Londoño M.C., Miquel R., Manzia T.M., Abraldes J.G., Lozano J.J., et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013, 58(5):1824-1835.
21. Salinas-Carmona M.C., Perez L.I., Galan K., Vazquez A.V. Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice. Autoimmunity 2009, 42(6):537-544.
22. Gronwall C., Kosakovsky Pond S.L., Young J.A., Silverman G.J. In vivo VL-targeted microbial superantigen induced global shifts in the B cell repertoire. J Immunol 2012, 189(2):850-859.
23. Karagiannis P., Gilbert A.E., Josephs D.H., et al. IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest 2013, 123(4):1457-1474.
24. Mauri C. Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol 2010, 22:761-767.